Cybin to Transfer U.S. Stock Exchange Listing to Nasdaq
Affected assets and topics
Why it matters
Cybin Inc. will transfer its U.S. stock exchange listing from NYSE American to the Nasdaq Global Market, with trading expected to cease on NYSE American at market close.
Article tone
Expected market reaction
Market impact analysis based on neutral sentiment with 80% confidence.
Evidence trail
Evidence
AI provenance
Technical identifiers
- Provider tag
- groq-llama-3.1-8b-instant
- Analysis version
- groq-llama-3.1-8b-instant
- Article id
- 24180
Original source
TORONTO, December 18, 2025--Cybin Inc. (NYSE American:CYBN) (Cboe CA:CYBN), a clinical-stage breakthrough pharmaceutical company committed to revolutionizing mental healthcare by developing innovative next-generation treatment options, today announced that it will voluntarily transfer its U.S. stock exchange listing to the Nasdaq Global Market ("Nasdaq") from the NYSE American LLC ("NYSE American"). The Company expects that its common shares will cease trading on the NYSE American at market clos
Read the full article on Yahoo Finance
Original article published by Yahoo Finance on December 18, 2025. Analysis and insights provided by AnalystMarkets AI.